Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM.

Lancet. 2007 Jul 7;370(9581):59-67. Review.

PMID:
17617273
2.

Comparative incidence of cancer in HIV-AIDS patients and transplant recipients.

Oliveira Cobucci RN, Saconato H, Lima PH, Rodrigues HM, Prudêncio TL, Junior JE, Giraldo PC, Gonçalves AK.

Cancer Epidemiol. 2012 Apr;36(2):e69-73. doi: 10.1016/j.canep.2011.12.002. Epub 2012 Jan 10. Review.

PMID:
22236649
3.

Risk of cancer in people with AIDS.

Grulich AE, Wan X, Law MG, Coates M, Kaldor JM.

AIDS. 1999 May 7;13(7):839-43.

PMID:
10357384
4.

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis.

Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM.

AIDS. 2002 May 24;16(8):1155-61.

PMID:
12004274
5.

Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.

Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosuppression and Cancer Study Group..

Eur J Cancer. 2007 Sep;43(14):2117-23. Epub 2007 Aug 30.

PMID:
17764927
6.

A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.

Srisawat N, Avihingsanon A, Praditpornsilpa K, Jiamjarasrangsi W, Eiam-Ong S, Avihingsanon Y.

Transplant Proc. 2008 Oct;40(8):2677-9. doi: 10.1016/j.transproceed.2008.07.061.

PMID:
18929833
7.

What types of cancers are associated with immune suppression in HIV? Lessons from solid organ transplant recipients.

Vajdic CM, van Leeuwen MT.

Curr Opin HIV AIDS. 2009 Jan;4(1):35-41. Review.

PMID:
19343829
8.

Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.

Busnach G, Piselli P, Arbustini E, Baccarani U, Burra P, Carrieri MP, Citterio F, De Juli E, Bellelli S, Pradier C, Rezza G, Serraino D; Immunosuppression and Cancer Study Group..

Transplant Proc. 2006 Dec;38(10):3533-5.

PMID:
17175324
9.

Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.

Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, Limina R, Castelli F, Quiros-Roldan E; Brescia HIV Cancer Study Group..

HIV Med. 2013 Sep;14(8):481-90. doi: 10.1111/hiv.12034. Epub 2013 Apr 7.

10.

Cancer incidence in AIDS patients in Catalonia, Spain.

Galceran J, Marcos-Gragera R, Soler M, Romaguera A, Ameijide A, Izquierdo A, Borràs J, de Sanjosé S, Casabona J.

Eur J Cancer. 2007 Apr;43(6):1085-91. Epub 2007 Mar 8.

PMID:
17349785
11.

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE.

BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.

12.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

13.

The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation.

Grulich AE, Vajdic CM.

Semin Oncol. 2015 Apr;42(2):247-57. doi: 10.1053/j.seminoncol.2014.12.029. Epub 2014 Dec 31. Review.

PMID:
25843729
14.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort..

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
15.
16.

Non-AIDS-defining cancers and HIV infection.

Lim ST, Levine AM.

Curr HIV/AIDS Rep. 2005 Aug;2(3):146-53. Review.

PMID:
16091262
18.

Cancer incidence in New York State acquired immunodeficiency syndrome patients.

Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ.

Am J Epidemiol. 2001 Sep 15;154(6):544-56.

PMID:
11549560
19.

HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.

Cooksley CD, Hwang LY, Waller DK, Ford CE.

Int J STD AIDS. 1999 Dec;10(12):795-802.

PMID:
10639060
20.

The risk of cancer in HIV-infected people in southeast England: a cohort study.

Newnham A, Harris J, Evans HS, Evans BG, Møller H.

Br J Cancer. 2005 Jan 17;92(1):194-200.

Supplemental Content

Support Center